The pattern of antiganglioside antibody reactivities producing myelinated nerve conduction block in vitro

Journal of the Neurological Sciences

Volumn 161, Issue 2, 1998, Pages 163-168

  Arasaki, Keisuke ^a   Kusunoki, Susumu ^b   Kudo, Norio ^c   Tamaki, Mitsuyuki ^a  

^a Kanto Teishin Hospital   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Anti ganglioside antibody; Conduction block; GD1b; GM1; Myelinated nerve fibers; Rat

Indexed keywords

DISACCHARIDE; GALACTOSE; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM1; IMMUNOGLOBULIN M ANTIBODY; N ACETYLGALACTOSAMINE;

ADOLESCENT; ADULT; ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MYELINATED NERVE; NERVE BLOCK; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; TIBIAL NERVE;

ACTION POTENTIALS; ADOLESCENT; ADULT; ANIMALS; ANTIGEN-ANTIBODY REACTIONS; DEMYELINATING DISEASES; EVOKED POTENTIALS; FEMALE; GANGLIOSIDES; HUMANS; MALE; MIDDLE AGED; NERVE BLOCK; NERVE FIBERS, MYELINATED; NEURAL CONDUCTION; RADICULOPATHY; RATS; RATS, WISTAR;

EID: 0032509138     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00283-4     Document Type: Article

References (19)

1. Arasaki K., Kusunoki S., Kudo N., Kanazawa I. Acute conduction block in vitro following exposure to antiganglioside sera. Muscle Nerve. 16:1993;587-593.
2. Brown EJ, Keith AJ, Frank MM. Complement. In: Paul WE, editor. Fundamental immunology. New York: Raven Press, 1984, 645-66.
3. Hartung H.-P., Pollard J.D., Harvey G.K., Toyka K.V. Immunopathogenesis and treatment of the Guillain-Barré syndrome - Part 1. Muscle Nerve. 18:1995;137-153.
4. Harvey G.K., Toyka K.V., Zielasek J., Kiefer R., Simonis C., Hartung H.-P. Failure of anti-GM1 IgG or IgM to induce conduction block following intraneural transfer. Muscle Nerve. 18:1995;388-394.
5. Hirota N., Kaji R., Bostock H., Shindo K., Kawasaki T., Mizutani K., Oka N., Kohara N., Saida T., Kimura J. The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons. Brain. 120:1997;2159-2169.
6. Ilyas A.A., Mithen F.A., Dalakas M.C., Chen Z.-W., Cook S.D. Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci. 107:1992;111-121.
7. Kusunoki S., Iwamori M., Chiba A., Hitoshi S., Arita M., Kanazawa I. GM1b is a new member of antigen for serum antibody in Guillain-Barré syndrome. Neurology. 47:1996;237-242.
8. Kusunoki S., Shimizu T., Chiba A., Ugawa Y., Hitoshi S., Kanazawa I. Experimental sensory neuropathy induced by sensitization with ganglioside GD1b. Ann Neurol. 39:1996;424-431.
9. Kusunoki S., Mashiko H., Mochizuki N., Chiba A., Arita M., Hitoshi S., Kanazawa I. Binding of antibodies against GM1 and GD1b in human peripheral nerve. Muscle Nerve. 20:1997;840-845.
10. Lange D.J., Trojaborg W. Do GM1 antibodies induce demyelination? Muscle Nerve. 17:1994;105-107.
11. O'Hanlon G.M., Paterson G.J., Wilson G., Doyle D., McHardie P., Willison H.J. Anti-GM1 ganglioside antibodies cloned from autoimmune neuropathy patients show diverse binding patterns in the rodent nervous system. J Neuropathol Exp Neurol. 55:1996;184-195.
12. Parry G.J.G., Sumner A.J. Multifocal motor neuropathy. Neurol Clin. 10:1991;671-684.
13. Parry G.J.G. Antiganglioside antibodies do not necessarily play a role in multifocal motor neuropathy. Muscle Nerve. 17:1994;97-99.
14. Pestronk A., Chaudhry V., Feldman E.L., Griffin J.W., Cornblath D.R., Denys E.H., Glasberg M., Kuncl R.W., Olney R.K., Yee W.C. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies. Ann Neurol. 27:1990;316-326.
15. Saida T., Saida K., Lisak R.P., Brown M.J., Silberberg D.H., Asbury A.K. In vivo demyelinating activity of sera from patients with Guillain-Barré syndrome. Ann Neurol. 11:1982;69-75.
16. Santoro M., Uncini A., Corbo M., Staugaitis S.M., Thomas F.P., Hays A.P., Latov N. Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann Neurol. 31:1992;385-390.
17. Schwerer B., Lassmann H., Bernheimer H. Ganglioside GM1, a molecular target for immunological and toxic attacks: similarity of neuropathological lesions induced by ganglioside-antiserum and cholera toxin. Acta Neuropathol. 72:1986;55-61.
18. + currents in isolated rat myelinated nerve fibers. Ann Neurol. 37:1995;436-442.
19. Uncini A., Santoro M., Corbo M., Lugaresi A., Latov N. Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies. Muscle Nerve. 16:1993;610-615.